ISRG

INTUITIVE SURGICAL INC

HealthcareCIK 0001035267

Loading...

Market Cap
$164.24B
P/E (TTM)
55.1x
Rev Growth (TTM)
+21.4%
Net Margin (TTM)
28.2%
FCF Yield (TTM)
1.7%
FCF Margin (TTM)
26.8%

Filings your agent reads

Factsheet

Primary-source SEC disclosures, read end-to-end — every figure traceable to its filing.

Point your agent at ISRG and it navigates these the same way — citing each number back to the filing.

LATEST EARNINGS

Q1 2026
2 months ago
View source
Revenue
$2.77B
Net Income
$826.00M
EPS
$2.28
+18.8%
Gross
66.1% +1.4%
Operating
30.9% +5.2%
Net
29.6% -1.4%
  • Worldwide procedures grew approximately 17% year-over-year, with da Vinci procedures up 16% and Ion procedures up 39%.
  • Da Vinci surgical system placements increased to 431 units, up from 367 in the prior year, with a significant portion (232 units) being the newer da Vinci 5 systems.
  • Revenue increased 23% year-over-year to $2.77 billion, driven by procedure volume, system placements, and installed base growth.
  • Non-GAAP diluted EPS grew significantly to $2.50, up from $1.81 in the prior year's quarter.

Cash Flow Health

Free Cash Flow8/8 positive
TTM$2.8B
Q1 '26
$809M+11%
Q4 '25
$730M-1%
FCF Margin
TTM26.8%
Q1 '2629.2%+15%
Sector: 0.0%Top 10%
OCF Margin31.8%
OCF/NI1.13x
CapEx Coverage6.4x
FCF Yield1.7%
FCF Growth (2Y)+41%
Cash Conversion Cycle
199 days
DSO: 47+DIO: 180DPO: 29

Capital Allocation & Returns

Balanced
Total Shareholder YieldTTM
TTM2.1%
Div Yield0.0%
+
Buyback (TTM)2.1%

Balancing returns with reinvestment

Dividend & Payout Metrics
Dividend Yield (TTM)0.0%
Free Cash Flow (TTM)$2.8B
Stock Repurchases (TTM)$3.4B
Capital Return / FCF120.6%
Est. Dividends Paid (TTM)$0
Shows how management rewards shareholders

Operational Efficiency & Returns

Return on Invested CapitalTTM
15.4%
Stable
+0.0% YoY+3.6%
P25MedianP75
75th pctl (med: -0.0%)
DuPont BreakdownROIC = Margin × Turn × (1+D/E)
NOPAT Margin
25.5%
8Q: 25.2%
Asset Turnover
0.53x
8Q: 0.50x
Leverage (1+D/E)
1.00x
D/E: 0.00x
DuPont: 13.5%15.4% ROIC
Asset & CapEx Efficiency
Fixed Asset Turn
2.05x
8Q:2.01x
+9.9%
Invested Cap Turn
0.84x
8Q:0.83x
+5.6%
CapEx Intensity
4.2%
8Q:5.1%
CapEx/Depreciation
31.15x
Asset-based ROIC formula

Valuation Analysis

Fair Value
Price-to-EarningsTTM
55.1x
Volatile
8Q: 262.6x-9013%
Valuation Lenses
Earnings
55.1x
vs sector
Cash Flow
56.1x
EV/FCF vs
Growth-Adj
2.6xPEG
Expensive for growth
Quality-Adj
3.6P/E per %ROIC
ROIC: 15.4%
Shareholder Returns
Dividend
Buyback
2.1%
Total Yield
2.1%
Market Cap$164.24B
EV$159.07B
Multi-angle valuation analysis with sector context

Business Quality & Moat

Overall Quality Score
90/100
Exceptional

Composite score: Returns (40%) + Consistency (30%) + Earnings Quality (30%)

Returns on Capital

Return on Equity (ROE)Top 25%
17.1%
8Q:
Return on Invested Capital (ROIC)Top 25%
15.4%
8Q:
+3.6%
vs Sector:-0.0%

DuPont Analysis (ROIC = NOPAT Margin × Asset Turnover)

NOPAT Margin: 25.5%
Asset Turnover: 0.53x

Earnings Quality

Cash Conversion

1.13x

OCF / Net Income

FCF Consistency

Positive quarters

Competitive Moat Indicators

Pricing Power

Gross Margin66.3%

Capital Efficiency

Invested Capital Turnover0.84x

Working Capital

Cash Conversion Cycle199 days

Growth Quality & Momentum

Quality Growth
Growth Quality Score
80/100
Growth 40%
Margins 30%
FCF 20%
Consistency 10%

Growth Rates

Revenue Growth YoY
21.4%
OpInc Growth YoY
48.0%
EPS Growth YoY
20.8%
FCF 3Y CAGR
41.2%

Growth Quality Analysis

Efficient Growth: Free cash flow growing faster than revenue
Sustainability Index: 8.5/10 - Highly sustainable growth

Margin Quality & Sustainability

High Quality
Profitability Cascade
Gross
66.3%
Operating
30.5%
Top 25% in sector
Net
28.2%
Margins Unknown
Earnings Quality Signals
SBC / Revenue
FCF vs Net Gap
-1.4 pts
FCF: 26.8% | Net: 28.2%

Quality = stability + cash conversion + low dilution

Balance Sheet & Solvency

Fortress
Net Debt / EBITDA
Net Cash
(0.0x)Net Cash: $4.52B
Interest Coverage
+Net cash position: $4.52B
Leverage Metrics
Debt-to-Equity
0.00x
Balance sheet risk & solvency analysis